For decades, the narrative around Parkinson’s disease treatment has focused primarily on dopamine replacement. The loss of ...

A 3D model accurately mimicking the Blood-Brain Barrier (BBB) in a laboratory environment has been successfully developed by research teams led by Professor Jinah Jang from the Departments of ...

Experts see tolebrutinib as part of a broader shift toward treatments that target the neurodegeneration in MS, not just its ...

More information: Elisa Nicoloso Simões‐Pires et al, Synergistic effects of the Aβ/fibrinogen complex on synaptotoxicity, neuroinflammation, and blood–brain barrier damage in Alzheimer's ...

Researchers discovered that people carrying the APOE ε4 gene variant share a unique immune-related protein signature across ...

The FDA approved an expanded access program for troculeucel, making the treatment available to patients outside clinical trials.

UCSF researchers find that two FDA-approved cancer drugs significantly improve memory in Alzheimer’s mouse models and reduce ...

The brain fog that can linger after a bout with COVID is not a new discovery. In fact, much research has linked this ...

A University of Minnesota Medical School-led research team has discovered that a cancer signaling pathway has previously unrecognized roles in retina and brain blood vessels. The findings were ...

More information: Elisa Nicoloso Simões‐Pires et al, Synergistic effects of the Aβ/fibrinogen complex on synaptotoxicity, neuroinflammation, and blood–brain barrier damage in Alzheimer's ...